Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Patients With Migraine
NCT01828684 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2016-03-31
Summary
Approximately 9% of men and 18% of women suffer from migraine headaches. Almost all migraine sufferers report light sensitivity during a headache. Some people with migraine report that light can trigger their migraines and some people with migraine are light sensitive all of the time. The investigators have recently determined that certain colors of light are more likely to trigger migraines than other colors. In this study the investigators want to know if people who wear glasses that block these colors of light will have fewer migraine headaches.
Conditions
- Migraine Disorders
- Photophobia
Interventions
- OTHER
-
Therapeutic Lens Coating
Subjects will wear a therapeutic lens coating for 2 weeks.
- OTHER
-
Sham Lens Coating
Each subject will wear a sham lens coating for 2 weeks.
Sponsors & Collaborators
-
Bradley Katz
lead OTHER
Principal Investigators
-
Bradley J Katz, MD · University of Utah
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2014-01-31
- Completion
- 2014-02-28
Countries
- United States
Study Locations
More Related Trials
-
Optical Treatment of Migraines Using the Avulux™ Optical Filter in the Form of Spectacle Lenses.
NCT03902496 ·Status: COMPLETED ·Phase: NA
-
Combined Effects of Green Light and Transcranial Direct Current Stimulation in Migraine Patients.
NCT06943625 ·Status: RECRUITING ·Phase: NA
-
Vitamin K2 Supplementation in Adult Episodic Migraine
NCT05943457 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Behavioral Insomnia Treatment for Chronic Migraine
NCT01314651 ·Status: COMPLETED ·Phase: NA
-
Prediction of Migraine Prevention Efficacy Based on Individual's Pain Modulation
NCT02101892 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
NCT03732638 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Topical Bimatoprost in the Treatment of Migraine
NCT03419715 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of a Transcranial Vibrating System for Mitigation of Migraine Associated Vertigo
NCT03886012 ·Status: SUSPENDED ·Phase: NA
-
Use of the Avulux® Lenses as an Aid in Reducing the Impact of Migraine Headaches
NCT04341298 ·Status: COMPLETED ·Phase: NA
-
Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine
NCT03398668 ·Status: COMPLETED ·Phase: NA
-
A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine
NCT00109083 ·Status: COMPLETED ·Phase: PHASE2
-
Migraine Headache Mitigation Utilizing Avulux
NCT06149000 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Migraine Prevention Using ActiPatch
NCT03166046 ·Status: COMPLETED ·Phase: NA
-
Study of Low-level Laser Therapy in the Acute Treatment of Migraine
NCT02969642 ·Status: UNKNOWN ·Phase: PHASE2
-
One-Day Intervention for Depression and Impairment in Migraine Patients
NCT02108678 ·Status: COMPLETED ·Phase: NA
-
A Study of Wearable Devices to Predict Migraines
NCT05755945 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Migraine With Aura Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow by Hypoxia
NCT01896167 ·Status: COMPLETED ·Phase: NA
-
Melatonin for Migraine Prevention
NCT00849511 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY2951742 in Participants With Migraine
NCT01625988 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions.
NCT03083860 ·Status: UNKNOWN ·Phase: NA
-
A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM
NCT06167655 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Treatment for Migraines With an Implantable Device
NCT00286078 ·Status: COMPLETED ·Phase: NA
-
Timolol Eye Drops in the Treatment of Acute Migraine Headache
NCT02630719 ·Status: TERMINATED ·Phase: NA
-
Transnasal Therapy for Acute Migraine Attack
NCT04129567 ·Status: COMPLETED ·Phase: NA
-
Neurolens Headache Study
NCT05070767 ·Status: COMPLETED ·Phase: NA